blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1247803

EP1247803 - Indolinone compounds suitable for modulation of protein kinases [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.07.2009
Database last updated on 24.08.2024
Most recent event   Tooltip17.07.2009Application deemed to be withdrawnpublished on 19.08.2009  [2009/34]
Applicant(s)For all designated states
Sugen, Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [2007/43]For all designated states
Sugen, Inc.
235 East 42nd Street
New York NY 10017 / US
Former [2002/41]For all designated states
Sugen, Inc.
230 E. Grand Avenue
South San Francisco, CA 94080 / US
Inventor(s)01 / Tang, Peng Cho
827 Camino Ricardo
Moraga, California 94556 / US
02 / Sun, Li
64 Rockharbor Lane
FosterCity, California 94404 / US
03 / McMahon, Gerald
1800 Schultz Road
Kenwood, California 95452 / US
04 / Hirth, Klaus Peter
334 Collingwood Street
San Francisco, California 94114 / US
05 / Shawver, Laura Kay
216 Cotter Street
San Francisco, California 94112 / US
 [2002/51]
Representative(s)Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte
Grillparzerstraße 14
81675 München / DE
[N/P]
Former [2008/28]Viering, Jentschura & Partner
Postfach 22 14 43
80504 München / DE
Former [2005/14]Viering, Jentschura & Partner
Steinsdorfstrasse 6
80538 München / DE
Former [2004/43]Nobbe, Matthias, Dr.
Viering, Jentschura & Partner Patent- und Rechtsanwälte Centroallee 263
46047 Oberhausen / DE
Former [2003/04]Harrison Goddard Foote
Quality House Quality Court Chancery Lane
London WC2A 1HT / GB
Former [2002/41]Moon, Donald Keith, et al
BREWER & SON Quality House Quality Court Chancery Lane
London WC2A 1HT / GB
Application number, filing date02077564.920.08.1997
[2002/41]
Priority number, dateUS1996070223223.08.1996         Original published format: US 702232
US19960031586P05.12.1996         Original published format: US 31586 P
US19960032547P05.12.1996         Original published format: US 32547 P
US19960031588P05.12.1996         Original published format: US 31588 P
US1996003254605.12.1996         Original published format: US 32546
US19960031585P05.12.1996         Original published format: US 31585 P
US19970045566P05.05.1997         Original published format: US 45566 P
US19970045715P05.05.1997         Original published format: US 45715 P
US19970045714P05.05.1997         Original published format: US 45714 P
US19970046843P05.05.1997         Original published format: US 46843 P
US19970045565P05.05.1997         Original published format: US 45565 P
[2002/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1247803
Date:09.10.2002
Language:EN
[2002/41]
Type: A3 Search report 
No.:EP1247803
Date:16.10.2002
[2002/42]
Search report(s)(Supplementary) European search report - dispatched on:EP29.08.2002
ClassificationIPC:C07D209/34, C07D409/06, C07D403/06, A61K31/40
[2002/41]
CPC:
C07D401/06 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/10 (EP); C07D209/34 (EP);
C07D403/06 (EP); C07D405/06 (EP); C07D409/06 (EP);
C07D455/06 (EP); C07D495/04 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/41]
TitleGerman:Indolinon-Verbindungen und deren Verwendung als Protein- Kinase-Modulatoren[2002/41]
English:Indolinone compounds suitable for modulation of protein kinases[2002/41]
French:Composés d'indolinone et leur utilisation comme modulateurs de la protéine kinase[2002/41]
Examination procedure13.02.2003Examination requested  [2003/16]
15.04.2004Despatch of a communication from the examining division (Time limit: M08)
01.12.2004Reply to a communication from the examining division
31.08.2006Despatch of a communication from the examining division (Time limit: M04)
29.12.2006Reply to a communication from the examining division
15.10.2008Despatch of a communication from the examining division (Time limit: M04)
26.02.2009Application deemed to be withdrawn, date of legal effect  [2009/34]
03.04.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/34]
Parent application(s)   TooltipEP97939480.6  / EP0929520
Fees paidRenewal fee
26.07.2002Renewal fee patent year 03
26.07.2002Renewal fee patent year 04
26.07.2002Renewal fee patent year 05
26.07.2002Renewal fee patent year 06
29.07.2003Renewal fee patent year 07
04.08.2004Renewal fee patent year 08
31.08.2005Renewal fee patent year 09
31.08.2006Renewal fee patent year 10
31.08.2007Renewal fee patent year 11
01.09.2008Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2968557  (LOTHAR BURGARDT, et al) [X] 1 * examples 4,10; claim - *;
 [X]WO9113055  (ERBA CARLO SPA [IT]) [X] 1-10 * the whole document *;
 [X]EP0525472  (ERBA CARLO SPA [IT]) [X] 1-10 * the whole document *;
 [X]EP0580502  (ADIR [FR]) [X] 4-10 * the whole document *;
 [X]WO9501349  (ERBA CARLO SPA [IT]) [X] 4-10 * the whole document *;
 [X]EP0662473  (PHARMACIA SPA [IT]) [X] 1-10 * the whole document *;
 [X]WO9600226  (PHARMACIA SPA [IT], et al) [X] 1-10 * example -; claim - *;
 [XD]WO9622976  (PHARMACIA SPA [IT], et al) [XD] 1-10 * example -; claim - *;
 [PX]WO9632380  (PHARMACIA SPA [IT], et al) [PX] 1-10* the whole document *;
 [DPX]WO9640116  (SUGEN INC [US]) [DPX] 4-10 * the whole document *;
 [X]  - ANDREANI, ALDO ET AL, "Potential antitumor agents. 25 [1]. Synthesis and cytotoxic activity of 3-(2-chloro-3-indolylmethylene)- 1,3-dihydroindol-2-ones", ANTICANCER RES. (1996), 16(6B), 3585-3588 CODEN: ANTRD4;ISSN: 0250-7005, (1996), XP002049948 [X] 1 * figure 1 *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein, XP002049949 [X] 5 * abstract *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein, XP002049950 [X] 5 * abstract *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein, XP002049951 [X] 5 * abstract *
 [X]  - VON DOBENECK, HENNING ET AL, "Indole chemistry. VI..alpha.,.beta.'-Diindolylmethanes and.alpha.,.beta.'-diindolylmethenes", CHEM. BER. (1969), 102(4), 1347-56, XP002209981 [X] 1-5 * page 1350 - page 1351 *
    [ ] - CODA ET AL., JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 2, LETCHWORTH GB, (1984), vol. 4, pages 615 - 620
    [ ] - WAHL; FAIVRET, ANN. CHIM., PARIS, (1926), page 350
    [ ] - ELLIOT; RIVERS, JOURNAL OF ORGANIC CHEMISTRY, EASTON US, (1964), vol. 29, page 2438
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.